Newsroom | 17502 results
Sorted by: Latest
-
Clarametyx Biosciences Announces Positive Topline Data From Phase 2a Study Evaluating CMTX-101 in Cystic Fibrosis
COLUMBUS, Ohio--(BUSINESS WIRE)--Clarametyx today announced positive topline data from a Phase 1b/2a trial evaluating its novel antibody therapy, CMTX-101, in cystic fibrosis (CF)....
-
Octave Bioscience Expands Leadership Team with Appointment of Kirk Stockwood Senior Vice President, Commercial
MENLO PARK, Calif.--(BUSINESS WIRE)--Octave Bioscience, Inc., a commercial stage precision medicine company pioneering biomarker driven solutions for multiple sclerosis, Parkinson’s disease and other neurodegenerative diseases today announced the appointment of Kirk Stockwood as Senior Vice President, Commercial. Mr. Stockwood will spearhead Octave’s commercial strategy as the company scales operations and expands the reach of its precision neurology platform. Mr. Stockwood brings over 20 years...
-
Dr. Jessica Ritch Opens EnRitched Gynecology, a New Membership-Based Women’s Health Practice
AVENTURA, Fla.--(BUSINESS WIRE)--Board-certified, fellowship-trained minimally invasive gynecologic surgeon Dr. Jessica Ritch today announced the opening of her new Monarch-affiliated practice on April 1, 2026. EnRitched Gynecology is an independent, membership-based women’s health practice designed to provide unrushed, deeply personal, and evidence-based care for women navigating menopause and complex gynecologic concerns. Opening April 1, 2026, EnRitched Gynecology will be located at Lina Med...
-
CharmHealth and PointClickCare Enable Real-Time Data Exchange Across Post-Acute Care
PLEASANTON, Calif.--(BUSINESS WIRE)--CharmHealth and PointClickCare will now offer bidirectional data exchange through a seamless integration, automating the flow of information....
-
Etiometry’s AI Platform Drives Measurable Outcomes as Hospitals Face Unprecedented Pressures
BOSTON--(BUSINESS WIRE)--Etiometry, a leader in AI-driven clinical intelligence, celebrates a year of significant achievements in 2025 and announces its vision to continue transforming critical care in the year ahead. In 2025, the company unveiled significant platform advancements, grew its number of hospital installations, secured its 10th FDA clearance, won a prestigious award, and showcased its clinical intelligence platform through numerous studies. Additionally, Etiometry continued focus o...
-
GoodRx Launches RxSmartSaver at Giant Eagle Pharmacies
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced the launch of RxSmartSaver powered by GoodRx at Giant Eagle pharmacies, giving patients a fast and easy way to access lower prices on high-cost brand medications directly at the pharmacy counter. “We are excited to partner with Giant Eagle to make brand medications more affordable and easier to access for the many patients who rely on them,” said David Graziano,...
-
NaphCare Chief Pharmacist, Dr. Darrelle Knight, Appointed to Alabama State Board of Pharmacy
BIRMINGHAM, Ala.--(BUSINESS WIRE)--NaphCare proudly congratulates Dr. Darrelle Knight on her appointment to the Institutional Non-hospital seat on the Alabama State Board of Pharmacy, effective January 1, 2026. The Alabama State Board of Pharmacy is a nine-member governing body that provides leadership and oversight for pharmacy practice in Alabama. Its responsibilities include licensure of pharmacy professionals and facilities, establishment of professional standards, and ensuring the safe and...
-
MUSC Health and Baxter Announce Strategic Partnership to Transform Bedside Care Delivery and Address Critical Nursing Challenges
CHARLESTON, S.C.--(BUSINESS WIRE)--MUSC Health and Baxter International Inc. (NYSE:BAX), a global medtech leader, are entering into a multi-year strategic partnership that aims to enhance the high-quality and safe patient care already delivered at MUSC Health, MUSC’s health care system, through integrated connected care technologies. By leveraging Baxter’s cutting-edge solutions and MUSC Health’s clinical and academic expertise, the partnership aims to help drive further improvements in nurse s...
-
GeneDx and Komodo Health Partner to Build the World’s Most Complete Longitudinal Rare Disease Dataset
GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx and Komodo Health Partner to Build the World’s Most Complete Longitudinal Rare Disease Dataset...
-
Rune Labs Taps Tempus Exec as New CEO to Expand AI-Enabled Neurology Care
SAN FRANCISCO--(BUSINESS WIRE)--Rune Labs, the leader in precision medicine for neurology, today announced Amy Gordon Franzen as its new Chief Executive Officer. Amy will lead the company’s next stage of growth, leveraging its success in Parkinson’s Disease, where it has established StrivePD as the industry’s preeminent AI platform and patient app. The company is actively expanding this platform to address additional neurological conditions, including Alzheimer’s disease and other forms of deme...